Clinical Trials

Inner Cosmos recently reported interim 36-month outcomes from a study of its psychiatric brain-computer interface technology. The company evaluated the safety and feasibility of...

EnVVeno Medical announced three-year outcomes for its heart valve that it aims to submit to the FDA this year. The company (formerly Hancock Jaffe)...

Apreo Health announced its emergence from stealth and an upcoming presentation of first-in-human clinical data for its emphysema treatment. Menlo Park, California-based Apreo develops the...

LumiThera has released new topline data for its Valeda Light Delivery System treatment for slowing the progression of dry age-related macular degeneration (AMD). LumiThera’s Valeda...

Inquis Medical has reported that the single-arm trial of its Aventus thrombectomy system in treating individuals with acute intermediate-risk pulmonary embolism (PE) met its...

Nuro announced a new clinical milestone with its third-generation neural operating system, NUOS 3. The company reports that NUOS 3 can enable patients who have...

FemDx Medsystems, a pioneering medical device company focused on advancing gynecological diagnostics, is proud to announce the successful completion of its first-in-human clinical study....

Perfuze announced it completed enrollment in its U.S. FDA investigational exemption (IDE) trial evaluating its stroke treatment. Galway, Ireland-based Perfuze also shared a new...

Fire1 announced positive results from the first-in-human study of its novel, implantable heart failure (HF) management system. The FUTURE-HF study evaluated the safety and feasibility...